MedPath

Evaluation of the effect of hyalase in treatment of keloids

Not Applicable
Recruiting
Conditions
keloid.
Hypertrophic scar
L91.0
Registration Number
IRCT20220115053715N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
16
Inclusion Criteria

Patients with keloid lesions based on clinical diagnosis or pathology who have not received any other treatments for at least 6 months prior to or at the same time as initiating treatment.

Exclusion Criteria

Patients with coagulation disorders or hematologic disorders such as hemophilia. Patients taking blood-thinning drugs such as aspirin.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath